Patel A - Search Results

1

The Unfolded Protein Response Is Associated with Cancer Proliferation and Worse Survival in Hepatocellular Carcinoma.

Patel A, Oshi M, Yan L, Matsuyama R, Endo I, Takabe K. Patel A, et al. Cancers (Basel). 2021 Sep 3;13(17):4443. doi: 10.3390/cancers13174443. Cancers (Basel). 2021. PMID: 34503253 Free PMC article.

2

A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.

Oshi M, Tokumaru Y, Patel A, Yan L, Matsuyama R, Endo I, Katz MHG, Takabe K. Oshi M, et al. Among authors: patel a. Cancers (Basel). 2020 Dec 4;12(12):3635. doi: 10.3390/cancers12123635. Cancers (Basel). 2020. PMID: 33291601 Free PMC article.

3

Organoids Are Limited in Modeling the Colon Adenoma-Carcinoma Sequence.

Tokumaru Y, Oshi M, Patel A, Tian W, Yan L, Matsuhashi N, Futamura M, Yoshida K, Takabe K. Tokumaru Y, et al. Among authors: patel a. Cells. 2021 Feb 25;10(3):488. doi: 10.3390/cells10030488. Cells. 2021. PMID: 33668713 Free PMC article.

4

G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.

Oshi M, Patel A, Le L, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K. Oshi M, et al. Among authors: patel a. Am J Cancer Res. 2021 Jun 15;11(6):3070-3084. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249445 Free PMC article.

5

Low expression of miR-195 is associated with cell proliferation, glycolysis and poor survival in estrogen receptor (ER)-positive but not in triple negative breast cancer.

Tokumaru Y, Oshi M, Patel A, Katsuta E, Yan L, Angarita FA, Dasgupta S, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Takabe K. Tokumaru Y, et al. Among authors: patel a. Am J Cancer Res. 2021 Jun 15;11(6):3320-3334. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249465 Free PMC article.

6

High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer.

Wu R, Patel A, Tokumaru Y, Asaoka M, Oshi M, Yan L, Ishikawa T, Takabe K. Wu R, et al. Among authors: patel a. Breast Cancer Res Treat. 2022 May;193(1):49-63. doi: 10.1007/s10549-022-06552-0. Epub 2022 Mar 6. Breast Cancer Res Treat. 2022. PMID: 35249172 Free PMC article.

7

Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment.

Takeshita T, Tokumaru Y, Oshi M, Wu R, Patel A, Tian W, Hatanaka Y, Hatanaka KC, Yan L, Takabe K. Takeshita T, et al. Among authors: patel a. Front Oncol. 2022 May 23;12:865024. doi: 10.3389/fonc.2022.865024. eCollection 2022. Front Oncol. 2022. PMID: 35677163 Free PMC article.

8

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer.

Oshi M, Patel A, Wu R, Le L, Tokumaru Y, Yamada A, Yan L, Matsuyama R, Ishikawa T, Endo I, Takabe K. Oshi M, et al. Among authors: patel a. NPJ Breast Cancer. 2022 Aug 9;8(1):92. doi: 10.1038/s41523-022-00466-2. NPJ Breast Cancer. 2022. PMID: 35945417 Free PMC article.

9

Melanoma trials that defined surgical management: Brief overview of current/upcoming adjuvant/neoadjuvant trials.

Patel A, Skitzki J. Patel A, et al. J Surg Oncol. 2022 Jan;125(1):38-45. doi: 10.1002/jso.26746. J Surg Oncol. 2022. PMID: 34897704 Review.

10

Smad4 restricts injury-provoked biliary proliferation and carcinogenesis.

Alexander WB, Wang W, Hill MA, O'Dell MR, Ruffolo LI, Guo B, Jackson KM, Ullman N, Friedland SC, McCall MN, Patel A, Figueroa-Guilliani N, Georger M, Belt BA, Whitney-Miller CL, Linehan DC, Murphy PJ, Hezel AF. Alexander WB, et al. Among authors: patel a. Dis Model Mech. 2024 Jun 1;17(6):dmm050358. doi: 10.1242/dmm.050358. Epub 2024 Feb 28. Dis Model Mech. 2024. PMID: 38415925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,988 results

Search Page